OCGN - AYX AKAM among premarket losers

Comstock Holding Companies (CHCI) -15%.VerifyMe (VRME) -15% on stock offering.Neovasc (NVCN) -14% on stock offering; pared yesterday's gains on patent news.Enlivex Therapeutics (ENLV) -13% on stock offering.Salem Media Group (SALM) -13%.Limbach Holdings (LMB) -12% on stock offering.VolitionRx (VNRX) -12% on stock offering.Cassava Sciences (SAVA) -11% on stock offering.Stealth BioTherapeutics (MITO) -12% on stock offering.Capstone Turbine (CPST) -12% on FQ3 earnings.Staffing 360 Solutions (STAF) -11% on stock offering.Hall of Fame Resort & Entertainment (HOFV) -10% on stock offering.Alteryx (AYX) -9% despite Q4 beat.Nxt-ID (NXTD) -7%.SemiLEDs (LEDS) -6%.Akamai Technologies (AKAM) -7% despite upside Q4 report; downgraded by JP Morgan.The ExOne (XONE) -7% on stock offering.Fluor (FLR) -7%.Ocugen (OCGN) -6%.Zosano Pharma (ZSAN) -7%.Outlook Therapeutics (OTLK) -6%.Autolus Therapeutics (AUTL) -6% on stock offering.Marathon Patent Group (MARA) -6%.Eastside Distilling (EAST) -6%.Purple Biotech (PPBT) -5%.Riot Blockchain (RIOT) -5%.Ballard Power Systems (BLDP) -5% on stock offering.

For further details see:

AYX, AKAM among premarket losers